166 related articles for article (PubMed ID: 38364715)
1. Design, synthesis, and bioactivity evaluation of novel indole-selenide derivatives as P-glycoprotein inhibitors against multi-drug resistance in MCF-7/ADR cell.
Yang Z; Luo D; Shao C; Hu H; Yang X; Cai Y; Mou X; Wu Q; Xu H; Sun X; Wang H; Hou W
Eur J Med Chem; 2024 Mar; 268():116207. PubMed ID: 38364715
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel phenylfuran-bisamide derivatives as P-glycoprotein inhibitors against multidrug resistance in MCF-7/ADR cell.
Yang Z; Yang X; Li Y; Cai Y; Yu Y; Zhuang W; Sun X; Li Q; Bao X; Ye X; Tian J; Wei B; Chen J; Wu Q; Zhang H; Mou X; Wang H
Eur J Med Chem; 2023 Feb; 248():115092. PubMed ID: 36645980
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 2,5-disubstituted furan derivatives featuring a benzamide motif for overcoming P-glycoprotein mediated multidrug resistance in MCF-7/ADR cell.
Yang Z; Cai Y; Mao S; Wu Q; Zhu M; Cao X; Wei B; Tian JM; Bao X; Ye X; Chen J; Wang S; Yu Y; Zhang H; Sun X; Cui ZN; Li YS; Wang H
Eur J Med Chem; 2023 Sep; 257():115462. PubMed ID: 37229830
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and bioactivity study on oxygen-heterocyclic-based pyran analogues as effective P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Abd El-Wahab AHF; Borik RMA; Al-Dies AM; Fouda AM; Mohamed HM; El-Eisawy RA; Mora A; El-Nassag MAA; Abd Elhady AM; Elhenawy AA; El-Agrody AM
Sci Rep; 2024 Mar; 14(1):7589. PubMed ID: 38555345
[TBL] [Abstract][Full Text] [Related]
6. Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity.
Yang Z; Cai Y; Yang X; Li Y; Wu Q; Yu Y; Chen Z; Wei B; Tian JM; Bao X; Ye X; Chen J; Zhang H; Mou X; Sun X; Wang H
J Med Chem; 2023 Apr; 66(8):5550-5566. PubMed ID: 37011035
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells.
Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA
Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992
[TBL] [Abstract][Full Text] [Related]
9. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
10. A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance.
Teng YN; Lin KI; Lin YC; Thang TD; Lan YH; Hung CC
Phytomedicine; 2021 May; 85():153528. PubMed ID: 33735724
[TBL] [Abstract][Full Text] [Related]
11. Jatrophane diterpenoids as multidrug resistance modulators from Euphorbia sororia.
Yang H; Mamatjan A; Tang D; Aisa HA
Bioorg Chem; 2021 Jul; 112():104989. PubMed ID: 34022709
[TBL] [Abstract][Full Text] [Related]
12. Carnosine Potentiates Doxorubicin-Induced Cytotoxicity in Resistant NCI/ADR-RES Cells by Inhibiting P-Glycoprotein-In Silico and In Vitro Evidence.
Morsy MA; Kandeel M; Ibrahim ARN; Abdel-Gaber SA; Jacob S; Venugopala KN; Shinu P; El-Daly M
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364209
[TBL] [Abstract][Full Text] [Related]
13. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
14. Discovery of (quinazolin-6-yl)benzamide derivatives containing a 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
Xue WH; Liu KL; Zhang TJ; Dong G; Wang JH; Wang J; Guo S; Hu J; Zhang QY; Li XY; Meng FH
Eur J Med Chem; 2024 Jan; 264():116039. PubMed ID: 38103540
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Biological Evaluation of Marine Lissodendrins B Analogues as Modulators of ABCB1-Mediated Multidrug Resistance.
Wang C; Zhang J; Wei X; Yang M; Ma W; Yu R; Liu M; Jiang T
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233508
[TBL] [Abstract][Full Text] [Related]
16. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein.
Mi Y; Lou L
Br J Cancer; 2007 Oct; 97(7):934-40. PubMed ID: 17912240
[TBL] [Abstract][Full Text] [Related]
17. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
[TBL] [Abstract][Full Text] [Related]
18. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells.
Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC
Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors.
Gao Y; Shi W; Cui J; Liu C; Bi X; Li Z; Huang W; Wang G; Qian H
Bioorg Med Chem; 2018 May; 26(9):2420-2427. PubMed ID: 29631786
[TBL] [Abstract][Full Text] [Related]
20. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
